Umer Rappat

Umer Raffat is a Senior Managing Director at Evercore ISI, where he heads coverage of large-cap therapeutics across biotech, major pharmaceuticals, and specialty pharmaceuticals. He covers prominent companies such as Amgen, Bristol-Myers Squibb, Merck, Cigna, and Humana, and has earned 22 first-place Institutional Investor rankings, although his TipRanks success rate is 38% with an average transaction return of -10.7%. Raffat began his equity research career at Deutsche Bank in 2010 under Dr. Mark Schoenebaum, moving to Evercore ISI shortly thereafter, and was inducted into the Institutional Investor Hall of Fame in 2020. He holds an undergraduate degree in biology from the University of Texas at Arlington and a master’s from the Harvard School of Public Health.